The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies.
Hypercholesterolemia is a clinically relevant condition with an ascertained role in atherogenesis. In particular, its presence directly correlates to the risk of atherosclerotic cardiovascular disease (ASCVD). As known, cardiovascular diseases pose a significant economic burden worldwide; however, a...
Guardado en:
Autores principales: | Pietro Ferrara, Danilo Di Laura, Paolo A Cortesi, Lorenzo G Mantovani |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f75a38b6008d431e9c3941c8efc6109f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
por: Hirotaka Fukami, et al.
Publicado: (2021) -
Genetic basis of hypercholesterolemia in adults
por: Seyedmohammad Saadatagah, et al.
Publicado: (2021) -
PROPORTION OF PSORIASIS IN FAMILIAL HYPERCHOLESTEROLEMIA
por: Samip Sheth, et al.
Publicado: (2021) -
Dyslipidemias in diabetes
por: HELENA W RODBARD
Publicado: (2004) -
A Systematic Review and Meta-Analysis of Therapeutic Efficacy and Safety of Alirocumab and Evolocumab on Familial Hypercholesterolemia
por: Xiaoyue Ge, et al.
Publicado: (2021)